Table 3.
Stage at diagnosis (advanced vs. localized)a | ||
---|---|---|
OR (95% CI) | P value | |
Marital status | ||
Married | Reference | – |
Unmarried | 1.52 (1.33, 1.73) | < 0.0001 |
Gender | ||
Female | Reference | – |
Male | 0.81 (0.74, 0.87) | < 0.0001 |
Age at diagnosis | ||
18–39 | 1.20 (1.01, 1.45) | 0.041 |
40–49 | 1.36 (1.78, 1.58) | < 0.0001 |
50–59 | Reference | – |
60–69 | 1.10 (0.98, 1.22) | 0.09 |
70–98 | 0.95 (0.85, 1.11) | 0.37 |
Pathological grading | ||
Well differentiated | 1.13 (0.90,1.40) | 0.27 |
Moderately differentiated | Reference | – |
Poorly differentiated | 2.27 (1.85, 2.79) | < 0.0001 |
Unknown | 0.93 (0.82, 1.10) | 0.33 |
Morphology | ||
Adenocarcinoma (AC), NOS | Reference | – |
Mucin-producing AC | 1.44 (0.95, 2.17) | 0.083 |
Mucinous AC | 1.39 (1.16, 1.67) | 0.0003 |
Signet ring cell carcinoma | 2.79 (1.16, 4.82) | 0.0002 |
AC in villous/tubuvillous adenoma | 0.38 (0.29, 0.49) | < 0.0001 |
Others | 0.40 (0.33, 0.47) | < 0.0001 |
Chemotherapy | ||
Yes | Reference | – |
No | 0.31 (0.28, 0.34) | < 0.0001 |
Surgery | ||
Yes | Reference | – |
No | 2.10 (1.88, 2.23) | < 0.0001 |
Radiotherapy | ||
Yes | Reference | – |
No | 0.81 (0.69, 0.96) | 0.015 |
aMultiple imputation-based analysis.